3,669
Views
73
CrossRef citations to date
0
Altmetric
Report

c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4

, , , &
Pages 1859-1872 | Received 19 Mar 2015, Accepted 09 Apr 2015, Published online: 17 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Emanuel Rosonina, Akhi Akhter, Yimo Dou, John Babu & Veroni S. Sri Theivakadadcham. (2017) Regulation of transcription factors by sumoylation. Transcription 8:4, pages 220-231.
Read now
Peter N Malak, Benjamin Dannenmann, Alexander Hirth, Oliver C Rothfuss & Klaus Schulze-Osthoff. (2015) Novel AKT phosphorylation sites identified in the pluripotency factors OCT4, SOX2 and KLF4. Cell Cycle 14:23, pages 3748-3754.
Read now
R Jürgen Dohmen. (2015) SUMO wrestles down myc. Cell Cycle 14:16, pages 2551-2552.
Read now

Articles from other publishers (70)

Kailang Li, Yongming Xia, Jian He, Jie Wang, Jingyun Li, Meng Ye & Xiaofeng Jin. (2023) The SUMOylation and ubiquitination crosstalk in cancer. Journal of Cancer Research and Clinical Oncology 149:17, pages 16123-16146.
Crossref
Matthew Hurd, Jeffrey Pino, Kay Jang, Michael M. Allevato, Marina Vorontchikhina, Wataru Ichikawa, Yifan Zhao, Ryan Gates, Emily Villalpando, Michael J. Hamilton, Francesco Faiola, Songqin Pan, Yue Qi, Yu-Wen Hung, Thomas Girke, David Ann, Victoria Seewaldt & Ernest Martinez. (2023) MYC acetylated lysine residues drive oncogenic cell transformation and regulate select genetic programs for cell adhesion-independent growth and survival. Genes & Development 37:19-20, pages 865-882.
Crossref
Xiaodong Cheng, Wenli Yang, Wei Lin & Fang Mei. (2023) Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?. Pharmacological Reviews 75:5, pages 979-1006.
Crossref
Daniel Salas-Lloret, Nicolette S. JansenEasa NagamalleswariCoen van der Meulen, Ekaterina GrachevaArnoud H. de RuH. Anne Marie OttePeter A. van Veelen, Andrea Pichler, Joachim Goedhart, Alfred C.O. Vertegaal & Román González-Prieto. (2023) SUMO-activated target traps (SATTs) enable the identification of a comprehensive E3-specific SUMO proteome. Science Advances 9:31.
Crossref
Han Sun Kim, Bo-Reum Kim, Thien T. P. Dao, Jin-Mo Kim, Yoon-Ju Kim, Hyunsong Son, Sihyang Jo, Doyeon Kim, Jiwoo Kim, Young Ju Suh, Hee-Je Kim, Byung-Sik Cho & Sunghyouk Park. (2023) TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently. Blood Advances 7:13, pages 3155-3168.
Crossref
Yunru Gu, Yuan Fang, Xi Wu, Tingting Xu, Tong Hu, Yangyue Xu, Pei Ma, Qiang Wang & Yongqian Shu. (2023) The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications. Experimental Hematology & Oncology 12:1.
Crossref
Chongyang Li, Alison Boutet, Cristina Mirela Pascariu, Trent Nelson, Mathieu Courcelles, Zhaoguan Wu, Simon Comtois-Marotte, Gregory Emery & Pierre Thibault. (2023) SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation. Journal of Proteome Research 22:3, pages 812-825.
Crossref
Dalila Boi, Elisabetta Rubini, Sara Breccia, Giulia Guarguaglini & Alessandro Paiardini. (2023) When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases. International Journal of Molecular Sciences 24:5, pages 4746.
Crossref
Nishant M. Karadkhelkar, Mingliang Lin, Lisa M. Eubanks & Kim D. Janda. (2023) Demystifying the Druggability of the MYC Family of Oncogenes. Journal of the American Chemical Society 145:6, pages 3259-3269.
Crossref
Maki Asami, Brian Y.H. Lam, Martin Hoffmann, Toru Suzuki, Xin Lu, Naoko Yoshida, Marcella K. Ma, Kara Rainbow, Miodrag Gužvić, Matthew D. VerMilyea, Giles S.H. Yeo, Christoph A. Klein & Anthony C.F. Perry. (2023) A program of successive gene expression in mouse one-cell embryos. Cell Reports 42:2, pages 112023.
Crossref
Ji Min Lee, Henrik M. Hammarén, Mikhail M. Savitski & Sung Hee Baek. (2023) Control of protein stability by post-translational modifications. Nature Communications 14:1.
Crossref
Santiago Vidal, Yanis Hichem Bouzaher, Ahmed El Motiam, Rocío Seoane & Carmen Rivas. (2022) Overview of the regulation of the class IA PI3K/AKT pathway by SUMO. Seminars in Cell & Developmental Biology 132, pages 51-61.
Crossref
Stefania Pieroni, Marilena Castelli, Danilo Piobbico, Simona Ferracchiato, Damiano Scopetti, Nicola Di-Iacovo, Maria Agnese Della-Fazia & Giuseppe Servillo. (2022) The Four Homeostasis Knights: In Balance upon Post-Translational Modifications. International Journal of Molecular Sciences 23:22, pages 14480.
Crossref
Alfred C. O. Vertegaal. (2022) Signalling mechanisms and cellular functions of SUMO. Nature Reviews Molecular Cell Biology 23:11, pages 715-731.
Crossref
Nieves Lara-Ureña, Vahid Jafari & Mario García-Domínguez. (2022) Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases. International Journal of Molecular Sciences 23:14, pages 8012.
Crossref
Marta Gomarasca, Giovanni Lombardi & Paola Maroni. (2022) SUMOylation and NEDDylation in Primary and Metastatic Cancers to Bone. Frontiers in Cell and Developmental Biology 10.
Crossref
Guangwen Wang, Yuhui Zhao, Yuan Zhou, Li Jiang, Libin Liang, Fandi Kong, Ya Yan, Xuyuan Wang, Yihan Wang, Xia Wen, Xianying Zeng, Guobin Tian, Guohua Deng, Jianzhong Shi, Liling Liu, Hualan Chen & Chengjun Li. (2022) PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence. PLOS Pathogens 18:4, pages e1010446.
Crossref
Umut Sahin, Hugues de Thé & Valérie Lallemand-Breitenbach. (2022) Sumoylation in Physiology, Pathology and Therapy. Cells 11:5, pages 814.
Crossref
Tomoya Muto, Maria Guillamot, Jennifer Yeung, Jing Fang, Joshua Bennett, Bettina Nadorp, Audrey Lasry, Luna Zea Redondo, Kwangmin Choi, Yixiao Gong, Callum S. Walker, Kathleen Hueneman, Lyndsey C. Bolanos, Laura Barreyro, Lynn H. Lee, Kenneth D. Greis, Nikita Vasyliev, Alireza Khodadadi-Jamayran, Evgeny Nudler, Amaia Lujambio, Scott W. Lowe, Iannis Aifantis & Daniel T. Starczynowski. (2022) TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity. Cell Stem Cell 29:2, pages 298-314.e9.
Crossref
Antti Kukkula, Veera K. Ojala, Lourdes M. Mendez, Lea Sistonen, Klaus Elenius & Maria Sundvall. (2021) Therapeutic Potential of Targeting the SUMO Pathway in Cancer. Cancers 13:17, pages 4402.
Crossref
Fang Xianjun, Xian Xirui, Tang Jie, Mu Huiwen, Zheng Shaojun, Ling Qiaoyun, Liu Yunxin & Sun Xuqun. (2021) Momordin Ic induces G0/1 phase arrest and apoptosis in colon cancer cells by suppressing SENP1/c-MYC signaling pathway. Journal of Pharmacological Sciences 146:4, pages 249-258.
Crossref
Xiao-Xin Sun, Yanping Li, Rosalie C. Sears & Mu-Shui Dai. (2021) Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy. Frontiers in Oncology 11.
Crossref
Jessie S. Kroonen & Alfred C.O. Vertegaal. (2021) Targeting SUMO Signaling to Wrestle Cancer. Trends in Cancer 7:6, pages 496-510.
Crossref
Ya-Chu Chang, Marissa K. Oram & Anja-Katrin Bielinsky. (2021) SUMO-Targeted Ubiquitin Ligases and Their Functions in Maintaining Genome Stability. International Journal of Molecular Sciences 22:10, pages 5391.
Crossref
Rohan Gupta & Pravir Kumar. (2021) Computational Analysis Indicates That PARP1 Acts as a Histone Deacetylases Interactor Sharing Common Lysine Residues for Acetylation, Ubiquitination, and SUMOylation in Alzheimer’s and Parkinson’s Disease. ACS Omega 6:8, pages 5739-5753.
Crossref
Mathias Boulanger, Mehuli Chakraborty, Denis Tempé, Marc Piechaczyk & Guillaume Bossis. (2021) SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic Studies. Molecules 26:4, pages 828.
Crossref
Szymon J. Szymura, Giovanna M. Bernal, Longtao Wu, Zhongqin Zhang, Clayton D. Crawley, David J. Voce, Paige-Ashley Campbell, Diana E. Ranoa, Ralph R. Weichselbaum & Bakhtiar Yamini. (2020) DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy. BMC Biology 18:1.
Crossref
Hui-Ming Chang & Edward T. H. Yeh. (2020) SUMO: From Bench to Bedside. Physiological Reviews 100:4, pages 1599-1619.
Crossref
Arda B. Celen & Umut Sahin. (2020) Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. The FEBS Journal 287:15, pages 3110-3140.
Crossref
Meijia Qian, Fangjie Yan, Tao Yuan, Bo Yang, Qiaojun He & Hong Zhu. (2020) Targeting post-translational modification of transcription factors as cancer therapy. Drug Discovery Today 25:8, pages 1502-1512.
Crossref
Zhiwei Wang, Yizuo Song, Miaomiao Ye, Xiaoming Dai, Xueqiong Zhu & Wenyi Wei. (2020) The diverse roles of SPOP in prostate cancer and kidney cancer. Nature Reviews Urology 17:6, pages 339-350.
Crossref
Ana Talamillo, Leiore Ajuria, Marco Grillo, Orhi Barroso-Gomila, Ugo Mayor & Rosa Barrio. (2020) SUMOylation in the control of cholesterol homeostasis. Open Biology 10:5.
Crossref
Marie-Eve Beaulieu, Francisco Castillo & Laura Soucek. (2020) Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein. Cells 9:4, pages 1038.
Crossref
Minyue Xie, Jie Yu, Shengfang Ge, Jian Huang & Xianqun Fan. (2020) SUMOylation homeostasis in tumorigenesis. Cancer Letters 469, pages 301-309.
Crossref
Yu Peng, Zhenxing Wang, Zhiqiang Wang, Fang Yu, Jiwen Li & Jiemin Wong. (2019) SUMOylation down-regulates rDNA transcription by repressing expression of upstream-binding factor and proto-oncogene c-Myc. Journal of Biological Chemistry 294:50, pages 19155-19166.
Crossref
Yingxiao Chen, Xiao-Xin Sun, Rosalie C. Sears & Mu-Shui Dai. (2019) Writing and erasing MYC ubiquitination and SUMOylation. Genes & Diseases 6:4, pages 359-371.
Crossref
Ramesh Kumar & Kanaga Sabapathy. (2019) RNF4—A Paradigm for SUMOylation‐Mediated Ubiquitination. PROTEOMICS 19:21-22.
Crossref
Manpreet Kalkat, Diana Resetca & Linda Z Penn. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 13 .
Mathias Boulanger, Rosa Paolillo, Marc Piechaczyk & Guillaume Bossis. (2019) The SUMO Pathway in Hematomalignancies and Their Response to Therapies. International Journal of Molecular Sciences 20:16, pages 3895.
Crossref
Alice Poppy Roworth, Simon Mark Carr, Geng Liu, Wojciech Barczak, Rebecca Louise MillerShonagh Munro, Alexander Kanapin, Anastasia Samsonova & Nicholas B. La Thangue. (2019) Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control. Science Advances 5:6.
Crossref
Dian Wang, Fan Bu & Weiwei Zhang. (2019) The Role of Ubiquitination in Regulating Embryonic Stem Cell Maintenance and Cancer Development. International Journal of Molecular Sciences 20:11, pages 2667.
Crossref
Brandon M. Fox, Andrew Janssen, Dagoberto Estevez-Ordonez, Florian Gessler, Nunzio Vicario, Gustavo Chagoya, Galal Elsayed, Houman Sotoudeh, William Stetler, Gregory K. Friedman & Joshua D. Bernstock. (2019) SUMOylation in Glioblastoma: A Novel Therapeutic Target. International Journal of Molecular Sciences 20:8, pages 1853.
Crossref
Xiao-Xin Sun, Yingxiao Chen, Yulong Su, Xiaoyan Wang, Krishna Mohan Chauhan, Juan Liang, Colin J. Daniel, Rosalie C. Sears & Mu-Shui Dai. (2018) SUMO protease SENP1 deSUMOylates and stabilizes c-Myc. Proceedings of the National Academy of Sciences 115:43, pages 10983-10988.
Crossref
Alba Kaci, Magdalena Keindl, Marie H. Solheim, Pål R. Njølstad, Lise Bjørkhaug & Ingvild Aukrust. (2018) The E3 SUMO ligase PIASγ is a novel interaction partner regulating the activity of diabetes associated hepatocyte nuclear factor-1α. Scientific Reports 8:1.
Crossref
Yi-Jia Li, Li Du, Grace Aldana-Masangkay, Xiuli Wang, Ryan Urak, Stephen J Forman, Steven T Rosen & Yuan Chen. (2018) Regulation of miR-34b/c-targeted gene expression program by SUMOylation. Nucleic Acids Research 46:14, pages 7108-7123.
Crossref
Piyou Ji, Shaohua Liang, Pengtao Li, Chengrong Xie, Jie Li, Kang Zhang, Xuqing Zheng, Min Feng, Qiu Li, Hui Jiao, Xiaoqin Chi, Wenxiu Zhao, Sheng Zhang & Xiaomin Wang. (2018) Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7. Biochemical and Biophysical Research Communications 502:1, pages 30-42.
Crossref
Manpreet Kalkat, Diana Resetca & Linda Z Penn. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 13 .
Christopher M. Hickey, Yang Xie & Mark Hochstrasser. (2018) DNA binding by the MATα2 transcription factor controls its access to alternative ubiquitin-modification pathways. Molecular Biology of the Cell 29:5, pages 542-556.
Crossref
Zhi-Jian Han, Yan-Hu Feng, Bao-Hong Gu, Yu-Min Li & Hao Chen. (2018) The post-translational modification, SUMOylation, and cancer (Review). International Journal of Oncology.
Crossref
L Liu, C C Wong, B Gong & J Yu. (2017) Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer. Oncogene 37:2, pages 148-159.
Crossref
María Victoria Ruiz-Pérez, Anna Frenzel & Marie Arsenian Henriksson. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules 3270 3279 .
Ramesh Kumar & Chit Fang Cheok. (2017) Dynamics of RIF1 SUMOylation is regulated by PIAS4 in the maintenance of Genomic Stability. Scientific Reports 7:1.
Crossref
J De Melo, S S Kim, C Lourenco & L Z Penn. (2017) Lysine-52 stabilizes the MYC oncoprotein through an SCFFbxw7-independent mechanism. Oncogene 36:49, pages 6815-6822.
Crossref
Sabine A.G. Cuijpers, Edwin Willemstein & Alfred C.O. Vertegaal. (2017) Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins. Molecular & Cellular Proteomics 16:12, pages 2281-2295.
Crossref
Einari A. Niskanen & Jorma J. Palvimo. (2017) Chromatin SUMOylation in heat stress: To protect, pause and organise?. BioEssays 39:6, pages 1600263.
Crossref
Manpreet Kalkat, Jason De Melo, Katherine Hickman, Corey Lourenco, Cornelia Redel, Diana Resetca, Aaliya Tamachi, William Tu & Linda Penn. (2017) MYC Deregulation in Primary Human Cancers. Genes 8:6, pages 151.
Crossref
Changjiang Luo, Yunyi Yao, Zeyuan Yu, Huinian Zhou, Lingyun Guo, Junqiang Zhang, Hongtai Cao, Genyuan Zhang, Yumin Li & Zuoyi Jiao. (2017) UBE2T knockdown inhibits gastric cancer progression. Oncotarget 8:20, pages 32639-32654.
Crossref
Ayan Chanda, Angela Chan, Lili Deng, Elizabeth N. Kornaga, Emeka K. Enwere, Donald G. Morris & Shirin Bonni. (2017) Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer. PLOS ONE 12:5, pages e0177639.
Crossref
Andrea Rabellino, Cristina Andreani & Pier Paolo Scaglioni. (2017) The Role of PIAS SUMO E3-Ligases in Cancer. Cancer Research 77:7, pages 1542-1547.
Crossref
Jacob-Sebastian Seeler & Anne Dejean. (2017) SUMO and the robustness of cancer. Nature Reviews Cancer 17:3, pages 184-197.
Crossref
Van G. Wilson. 2017. SUMO Regulation of Cellular Processes. SUMO Regulation of Cellular Processes 1 12 .
Ivo A. Hendriks & Alfred C. O. Vertegaal. (2016) A comprehensive compilation of SUMO proteomics. Nature Reviews Molecular Cell Biology 17:9, pages 581-595.
Crossref
Jane J. Thomas, Mona Abed, Julian Heuberger, Rostislav Novak, Yaniv Zohar, Angela P. Beltran Lopez, Julie S. Trausch-Azar, Ma. Xenia G. Ilagan, David Benhamou, Gunnar Dittmar, Raphael Kopan, Walter Birchmeier, Alan L. Schwartz & Amir Orian. (2016) RNF4-Dependent Oncogene Activation by Protein Stabilization. Cell Reports 16:12, pages 3388-3400.
Crossref
Frauke Liebelt & Alfred C. O. Vertegaal. (2016) Ubiquitin-dependent and independent roles of SUMO in proteostasis. American Journal of Physiology-Cell Physiology 311:2, pages C284-C296.
Crossref
Andrea Rabellino, Margherita Melegari, Van S. Tompkins, Weina Chen, Brian G. Van Ness, Julie Teruya-Feldstein, Maralice Conacci-Sorrell, Siegfried Janz & Pier Paolo Scaglioni. (2016) PIAS1 Promotes Lymphomagenesis through MYC Upregulation. Cell Reports 15:10, pages 2266-2278.
Crossref
Marco P. Licciardello & Stefan Kubicek. (2016) Pharmacological treats for SUMO addicts. Pharmacological Research 107, pages 390-397.
Crossref
María Victoria Ruiz-Pérez, Anna Frenzel & Marie Arsenian Henriksson. 2016. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules 1 10 .
Jorrit M. Enserink. (2015) Sumo and the cellular stress response. Cell Division 10:1.
Crossref
Karolin Eifler & Alfred C.O. Vertegaal. (2015) SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer. Trends in Biochemical Sciences 40:12, pages 779-793.
Crossref
Chun-Jie HuangDi WuFaheem Ahmed KhanLi-Jun Huo. (2015) DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event. DNA and Cell Biology 34:11, pages 652-660.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.